ArticleBMC cancer2018
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.
Dandan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleBMC cancer2018
Dandan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.